C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 241/04 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61P 3/00 (2006.01)
Patent
CA 2589483
Compounds of Formula (I): Chemical formula should be inserted here as it appears on the abstract in paper form. or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
La présente invention a trait à des composés de formule (I), ou leurs sels, solvates ou esters pharmaceutiquement acceptables, utiles dans le traitement de maladies ou conditions où sont impliqués les récepteurs CB1, tels que le syndrome métabolique et l'obésité, les troubles neuroinflammatoires, les troubles cognitifs et la psychose, l'accoutumance (par exemple, le sevrage du tabac), les troubles gastro-intestinaux, et les conditions cardio-vasculaires.
Gilbert Eric J.
Greenlee William J.
Miller Michael W.
Scott Jack D.
Stamford Andrew W.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Substituted piperazines as cb1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted piperazines as cb1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperazines as cb1 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1763966